Amer M. Zeidan, MD¹, Kiyoshi Ando, MD, PhD², Odile Rauzy^3*, Mehmet Turgut, MD^4*, Ming-Chung Wang, MD^5*, Roberto Cairoli^6*, Hsin-An Hou, MD, PhD^7*, Yok-Lam Kwong, MD^8*, Montserrat Arnan Sangerman, PhD^9*, Stef Meers¹⁰, Vinod A. Pullarkat, MD^11*, Valeria Santini, MD, PhD^12*, Kamel Malek^13*, Flavia Kiertsman^14*, Jiaying Lyu^15*, Pedro Marques Ramos, PhD^13*, Pierre Fenaux¹⁶, Yasushi Miyazaki, MD¹⁷ and Uwe Platzbecker, MD¹⁸

¹Yale University and Yale Cancer Center, New Haven, CT
²Tokai University School of Medicine, Isehara, Japan
³Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁴Ondokuz Mayıs University, Samsun, Turkey
⁵Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
⁶Niguarda Cancer Center, Milan, Italy
⁷National Taiwan University Hospital, Taipei City, Taiwan
⁸Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
⁹Institut Català d'Oncologia-Hospital Duran i Reynals, Barcelona, Spain
¹⁰AZ Klina, Brasschaat, Belgium
¹¹City of Hope, Duarte, CA
¹²University of Florence, Florence, Italy
¹³Novartis Pharma AG, Basel, Switzerland
¹⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁵Novartis, China, Shanghai, China
¹⁶Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
¹⁷Nagasaki University, Nagasaki, Japan
¹⁸University Hospital Leipzig, Leipzig, Germany

Michael R. Savona, MD¹, James K McCloskey, MD², Elizabeth A. Griffiths, MD³, Karen Yee, MD⁴, Amer M. Zeidan, MD⁵, Aref Al-Kali, MD⁶, Joachim Deeg, MD^7*, Prapti Patel, MD⁸, Mitchell Sabloff, MSc, MD, FRCPC⁹, Mary-Margaret Keating, MD, FRCPC¹⁰, Kim-Hien Dao, DO^11,12, Nancy Zhu, MD^13*, Nashat Y. Gabrail, MD^14*, Salman Fazal, MD¹⁵, Joseph J. Maly, MD¹⁶, Olatoyosi Odenike, MD¹⁷, Hagop Kantarjian, MD¹⁸, Amy E. DeZern, MD¹⁹, Casey L. O'Connell, MD²⁰, Gail J. Roboz, MD²¹, Lambert Busque, MD²², Rena Buckstein²³, Harshad Amin, MD^24*, Jasleen K. Randhawa, MD²⁵, Brian Leber, MD^26,27, Aram Oganesian, PhD^11*, Winny Chan, PharmD^11*, Yong Hao, MD, PhD^11*, Mohammad Azab, MD¹¹ and Guillermo Garcia-Manero, MD²⁸

¹Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
²John Thuerer Cancer Center, Hackensack Medical Center, Hackensack, NJ
³Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Hematology, Yale University and Yale Cancer Center, New Haven, CT
⁶Mayo Clinic, Rochester, Rochester, MN
⁷Fred Hutchinson Cancer Center, Seattle, WA
⁸University of Texas Southwestern Medical Center, Dallas, TX
⁹Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada
¹⁰Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
¹¹Astex Pharmaceuticals, Inc., Pleasanton, CA
¹²Oregon Health & Science University, Portland, OR
¹³University of Alberta, Edmonton, AB, Canada
¹⁴Gabrail Cancer Center, Canton, OH
¹⁵West Penn Hospital, Allegheny Health Network, Pittsburgh, PA
¹⁶Norton Cancer Institute, Louisville, KY
¹⁷University of Chicago, Chicago, IL
¹⁸The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁹The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
²⁰USC Keck School of Medicine, University of Southern California, Los Angeles, CA
²¹Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
²²Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
²³Division of Hematological Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
²⁴Boca Raton Clinical Research, Boca Raton, FL
²⁵Houston Methodist Research Institute, Houston, TX
²⁶McMaster University, Hamilton, ON, Canada
²⁷Juravinski Cancer Centre, Hamilton, ON, Canada
²⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

David A. Sallman, MD¹, Amy E. DeZern, MD², Arlene A. Gayle, MD³, Stuart J. Kahn, MD^4*, Eric Padron, MD⁵, Jeffrey E. Lancet, MD⁶, Andrew Kuykendall, MD⁷, Kendra Sweet, MD⁸, Onyee Chan, MD⁷, Dean Y. Maeda, PhD^4*, Aaron D. Schuler, PhD^4*, John A. Zebala, MD, PhD^4* and Rami S. Komrokji⁹

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
³AdventHealth Orlando, Orlando, FL
⁴Syntrix Pharmaceuticals, Auburn, WA
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
⁶Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. %26 Rsrch. Institute, Tampa, FL
⁷Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
⁹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Anna Stengel, PhD, Manja Meggendorfer, PhD, Wencke Walter, PhD^*, Constance Baer, PhD, Niroshan Nadarajah^*, Stephan Hutter, PhD^*, Wolfgang Kern, MD, Torsten Haferlach, MD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Waled Bahaj, MD^1,2, Tariq Kewan, MD^3,4*, Carmelo Gurnari, MD^1,5, Arda Durmaz^1*, BEN Ponvilawan, MD^1*, Ishani Pandit^1*, Yasuo Kubota, MD, PhD^1*, Olisaemeka Ogbue⁶, Mai Aly, MD, BSc, MS^1,7*, Yazan F. Madanat, MD⁸, Taha Bat, MD⁹, Suresh Kumar Balasubramanian, MD¹⁰, Minako Mori, MD, PhD^1*, Manja Meggendorfer, PhD¹¹, Hetty E. Carraway, MD, MBA¹², Sudipto Mukherjee, MD, PhD, MPH¹², Mikkael A. Sekeres, MD¹³, Torsten Haferlach, MD¹¹, Valeria Visconte, PhD¹ and Jaroslaw P. Maciejewski, MD, PhD, FACP¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Brown Cancer Center, University of Louisville, Louisville, KY
³Smilow Cancer Center, Yale New Haven Hospital, New Haven, CT
⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, OH
⁵Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy
⁶Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Rocky River, OH
⁷Assiut University, Clinical Hematology unit, Faculty of Medicine, Assiut, Egypt
⁸Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
⁹Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX
¹⁰Department of Oncology, Wayne State University/ Karmanos Cancer Institute, Detroit, MI
¹¹MLL Munich Leukemia Laboratory, Munich, Germany
¹²Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
¹³University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL

Guillermo Garcia-Manero, MD¹, Vera Adema, PhD^2*, Samuel Urrutia, MD^2*, Feiyang Ma, PhD^3*, Hui Yang, MD, PhD², Irene Ganan-Gomez, PhD², Gautam Borthakur, MD², Koichi Takahashi, MD, PhD⁴, Nicholas Short, MD², Ghayas C. Issa, MD², Kelly S. Chien, MD², Guillermo Montalban-Bravo, MD², Joby Joseph^2* and Simona Colla, PhD^2*

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX